These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27448450)

  • 1. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
    Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
    Oncol Rep; 2016 Apr; 35(4):2382-90. PubMed ID: 26882953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
    Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
    Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
    Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
    Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma.
    He L; Fan X; Li Y; Chen M; Cui B; Chen G; Dai Y; Zhou D; Hu X; Lin H
    Cell Death Dis; 2019 Jun; 10(6):444. PubMed ID: 31168049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
    Tsuchiya H; Oura S
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.
    Huang XH; Jian WH; Wu ZF; Zhao J; Wang H; Li W; Xia JT
    Oncotarget; 2014 Jul; 5(14):5570-80. PubMed ID: 25015194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
    Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
    Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
    Hong M; Almutairi MM; Li S; Li J
    Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
    Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
    J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.